Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

Abstract Objectives A diverse intratumoral T‐cell receptor (TCR) repertoire is associated with improved survival in diffuse large B‐cell lymphoma (DLBCL) treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy. We explored the impact of intratumoral T...

Full description

Bibliographic Details
Main Authors: Mohamed Shanavas, Soi‐Cheng Law, Mark Hertzberg, Rodney J Hicks, John F Seymour, Zhixiu Li, Lilia Merida de Long, Karthik Nath, Muhammed B Sabdia, Jay Gunawardana, Maher K Gandhi, Colm Keane
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Clinical & Translational Immunology
Subjects:
immunotherapy
interim PET
lymphoma
TCR repertoire
Online Access:https://doi.org/10.1002/cti2.1351

Internet

https://doi.org/10.1002/cti2.1351

Similar Items